![Sean Stalfort](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Stalfort
Directeur/Membre du Conseil chez
TAYSHA GENE THERAPIES, INC.
Fortune : 14 M $ au 31/08/2026
Profil
Sean Stalfort was the founder of Benevolent Capital Partners LLC (Private Equity), founded in 2005, where the title held was Founding Partner from 2005 to 2010.
Mr. Stalfort is the founder of PBM Capital Group LLC, founded in 2010, holding the titles of Chairman and CEO since 2010.
Current jobs include Director at PBM Pharmaceuticals, Inc., Director at Tolerion, Inc., Director at Xalud Therapeutics, Inc., Director at Verrica Pharmaceuticals, Inc. since 2015, Board of Directors at Novartis Gene Therapies Switzerland GmbH, Independent Director at Taysha Gene Therapies, Inc. since 2023, Director at SalioGen Therapeutics, Inc., Director at Baxis Pharmaceuticals, Inc., Director at Vetana Animal Health, Inc., Independent Director at Acumen Pharmaceuticals, Inc. since 2018, Partner at Octagon Partners LLC, and Partner at Octagon Finance LLC.
Former jobs include Director at Perrigo Co., Director at Genapure Corp., Director at Candel Therapeutics, Inc., Director at Dova Pharmaceuticals, Inc. from 2016 to 2019, Director at Quantapore, Inc., Senior Underwriter at NatWest Markets Securities, Inc. in 2004, Vice President at Greenwich Capital Holdings, Inc. in 1996, Executive Vice President-New Business Development at PBM Products LLC, Investment Banking Associate at CS First Boston Pacific, Inc. in 1992, Senior Vice President-Capital Markets at Enterprise Mortgage Acceptance Co. LLC, Senior Vice President at Koch Financial Corp., and Founding Partner at Ravelin Capital Group LLC.
Education includes undergraduate degrees from Brown University, conferred in 1991, and the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 2 060 849 ( 0,76% ) | 12 M $ | 31/08/2026 | |
| 08/04/2026 | 187 380 ( 1,09% ) | 1 M $ | 31/08/2026 | |
| 03/06/2026 | 316 719 ( 0,44% ) | 902 649 $ | 31/08/2026 |
Postes actifs de Sean Stalfort
| Sociétés | Poste | Début |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/12/2015 |
| ACUMEN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 06/11/2025 |
| TAYSHA GENE THERAPIES, INC. | Directeur/Membre du Conseil | 21/06/2023 |
Octagon Partners LLC
 Octagon Partners LLC Real Estate DevelopmentFinance Operates real estate agents and managers | Corporate Officer/Principal | - |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Novartis Gene Therapies Switzerland GmbH | Directeur/Membre du Conseil | - |
Vetana Animal Health, Inc.
 Vetana Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals who suffer from inflammatory diseases | Directeur/Membre du Conseil | - |
Baxis Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology Develops non-viral gene therapies | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Sean Stalfort
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sean Stalfort
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets self-care products and solutions | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
NatWest Markets Securities, Inc.
 NatWest Markets Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Octagon Partners LLC
Octagon Partners LLC Real Estate DevelopmentFinance Operates real estate agents and managers | Finance |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich Capital Holdings, Inc.
 Greenwich Capital Holdings, Inc. Major BanksFinance Provides retail and commercial banking services | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables Markets and distributes nutritional and pharmaceutical products | Consumer Non-Durables |
CS First Boston Pacific, Inc. | |
Genapure Corp.
 Genapure Corp. Miscellaneous Commercial ServicesCommercial Services Provides outsourced environmental, food, and pharmaceutical testing services | Commercial Services |
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides capital and financing options for equipment financing and business loans | Commercial Services |
Koch Financial Corp. /Municipal Lending Business/
 Koch Financial Corp. /Municipal Lending Business/ Finance/Rental/LeasingFinance Provides municipal lending services | Finance |
Benevolent Capital Partners LLC (Private Equity)
 Benevolent Capital Partners LLC (Private Equity) Investment ManagersFinance Benevolent Capital Partners invests in small to middle market companies located in the United States. The firm focuses on companies operating in a broad range of sectors and industries. It provides financing for early stage capital requirements and participates in MBOs, acquisitions, debt, and equity transactions. | Finance |
Ravelin Capital Group LLC
 Ravelin Capital Group LLC Investment ManagersFinance Operates as a private equity firm | Finance |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Finance |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Develops nanopore based nucleic acid sequencing technology | Health Technology |
Octagon Finance LLC
 Octagon Finance LLC Financial ConglomeratesFinance Provides financial services | Finance |
Novartis Gene Therapies Switzerland GmbH | |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
SalioGen Therapeutics, Inc.
SalioGen Therapeutics, Inc. BiotechnologyHealth Technology Develops non-viral gene therapies | Health Technology |
Baxis Pharmaceuticals, Inc. | |
Vetana Animal Health, Inc.
Vetana Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals who suffer from inflammatory diseases | Health Technology |
